Sequencing Treatments for Mothers With ADHD and Their At - Risk Children

Completed · Phase 4

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

We hypothesize that successfully treating maternal Attention Deficit Hyperactivity Disorder (ADHD) will have a beneficial effect that extends to the child. We believe that multi-component interventions combining maternal stimulant medication, Lisdexamfetamine (LDX), and Behavioral Parent Training (BPT) will improve parenting, maternal, and child outcomes. In terms of improved parenting, we hypothesize that some mothers may respond well to LDX or BPT alone and therefore may not require multi-modal treatment, whereas others may benefit most from multi-modal treatment

Key facts

Study ID
NCT01816074
Run by
Seattle Children's Hospital
People needed
53
Starts
2012-10-01
Expected to finish
2017-05-01
Last updated by the study team
2018-10-09

Who can join

Age: 21 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.